Balance Sheet Vineet Laboratories Limited

Stocks

VINEETLAB

INE505Y01010

Pharmaceuticals

Market Closed - NSE India S.E. 19:05:11 21/08/2026 HKT			5-day change	1st Jan Change
37.81 ^INR	-1.77%		+1.39%	+2.80%

07-22	Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026	CI
05-29	Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026	CI

eca8917cd7931.TMInzKwVVa-FJiKN28usSZu2tNc25PufSVj6Z6K9r48.NLF0ouBTAsnIaE_6k6jfK9f9jLAGoprrAgi9Ftbs_u45t0O_wX8W6tRUQQ

Published financial data: VINEET LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2.43B	1.91B	2.12B	1.51B	750M
Other Revenues, Total	-	-	-	3.73M	19.58M
Total Revenues	2.43B	1.91B	2.12B	1.51B	770M
Cost of Goods Sold, Total	2B	1.5B	1.76B	1.18B	731M
Gross Profit	435M	414M	362M	329M	38.77M
Selling General & Admin Expenses, Total	56.38M	50.3M	60.71M	64.83M	53.75M
Depreciation & Amortization - (IS)	18.07M	20.16M	23.73M	25.19M	25.02M
Other Operating Expenses	297M	231M	221M	189M	128M
Other Operating Expenses, Total	371M	302M	306M	279M	207M
Operating Income	63.5M	112M	56.24M	50.54M	-168M
Interest Expense, Total	-26.67M	-21.68M	-26.58M	-38.49M	-38.31M
Interest And Investment Income	462K	1.62M	1.23M	354K	-
Net Interest Expenses	-26.2M	-20.06M	-25.35M	-38.14M	-38.31M
Currency Exchange Gains (Loss)	2.74M	915K	-3.37M	68K	42K
Other Non Operating Income (Expenses)	541K	315K	-7.22M	-9.32M	-1.47M
EBT, Excl. Unusual Items	40.58M	93.46M	20.3M	3.15M	-208M
Gain (Loss) On Sale Of Investments	-	-	-	481K	247K
EBT, Incl. Unusual Items	40.58M	93.46M	20.3M	3.63M	-208M
Income Tax Expense	22.78M	27.07M	7.77M	-6.64M	-5.84M
Earnings From Continuing Operations	17.8M	66.39M	12.52M	10.27M	-202M
Net Income to Company	17.8M	66.39M	12.52M	10.27M	-202M
Net Income - (IS)	17.8M	66.39M	12.52M	10.27M	-202M
Net Income to Common Incl Extra Items	17.8M	66.39M	12.52M	10.27M	-202M
Net Income to Common Excl. Extra Items	17.8M	66.39M	12.52M	10.27M	-202M
Per Share Items
Net EPS - Basic	1.93	7.2	1.36	1.11	-21.9
Basic EPS - Continuing Operations	1.93	7.2	1.36	1.11	-21.9
Basic Weighted Average Shares Outstanding	9.22M	9.22M	9.22M	9.22M	9.22M
Net EPS - Diluted	1.93	7.2	1.36	1.11	-21.9
Diluted EPS - Continuing Operations	1.93	7.2	1.36	1.11	-21.9
Diluted Weighted Average Shares Outstanding	9.22M	9.22M	9.22M	9.22M	9.22M
Normalized Basic EPS	2.75	6.34	1.38	0.21	-14.1
Normalized Diluted EPS	2.75	6.34	1.38	0.21	-14.1
Dividend Per Share	-	1	-	-	-
Payout Ratio	-	-	73.6	-	-
Supplemental Items
EBITDA	81.57M	132M	79.97M	74.27M	-143M
EBITA	63.5M	112M	56.24M	50.54M	-168M
EBIT	63.5M	112M	56.24M	50.54M	-168M
EBITDAR	81.91M	133M	80.15M	74.66M	-143M
Total Revenues (As Reported)	2.44B	1.91B	2.12B	1.51B	770M
Effective Tax Rate - (Ratio)	56.13	28.97	38.3	-182.64	2.81
Total Current Taxes	12.79M	31.83M	5.6M	-648K	-
Total Deferred Taxes	9.99M	-4.76M	2.17M	-5.99M	-5.84M
Normalized Net Income	25.36M	58.41M	12.69M	1.97M	-130M
Interest on Long-Term Debt	20.34M	2.24M	3.38M	7.11M	4.83M
Non-Cash Pension Expense	-	525K	-9K	633K	712K
Supplemental Operating Expense Items
Advertising Expense	330K	750K	502K	591K	49K
Selling and Marketing Expenses	330K	750K	502K	591K	49K
Net Rental Expense, Total	344K	458K	182K	394K	345K
Imputed Operating Lease Interest Expense	-	408K	134K	322K	251K
Imputed Operating Lease Depreciation	-	50.42K	47.61K	72.13K	94.3K
Maintenance & Repair Expenses, Total	19.12M	42.02M	37.72M	41.37M	28.38M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	21.02M	181M	6.31M	2.28M	3.07M
Total Cash And Short Term Investments	21.02M	181M	6.31M	2.28M	3.07M
Accounts Receivable, Total	427M	362M	352M	316M	132M
Other Receivables	-	-	296K	586K	-
Total Receivables	427M	362M	352M	317M	132M
Inventory	397M	435M	462M	494M	500M
Other Current Assets, Total	18.61M	48.74M	54.66M	69.04M	38.69M
Total Current Assets	864M	1.03B	875M	882M	674M
Gross Property Plant And Equipment	355M	392M	469M	496M	507M
Accumulated Depreciation	-158M	-178M	-202M	-227M	-252M
Net Property Plant And Equipment	197M	214M	266M	269M	255M
Long-term Investments	1.18M	1.36M	1.34M	1.82M	2.06M
Accounts Receivable Long-Term	13.34M	40.34M	-	-	-
Other Long-Term Assets, Total	12.62M	53.48M	16.07M	15.87M	14.81M
Total Assets	1.09B	1.34B	1.16B	1.17B	945M
Liabilities
Accounts Payable, Total	560M	601M	349M	323M	336M
Accrued Expenses, Total	23.28M	20.18M	23.68M	30.07M	35.06M
Short-term Borrowings	90.07M	248M	252M	391M	353M
Current Portion of Long-Term Debt	-	-	10.43M	13.2M	9.86M
Current Income Taxes Payable	12.41M	31.83M	4.4M	1.22M	-
Unearned Revenue Current, Total	1.5M	-	-	-	-
Other Current Liabilities	59.36M	49.99M	106M	1.96M	10.1M
Total Current Liabilities	746M	951M	745M	760M	744M
Long-Term Debt	34.66M	17.22M	48.48M	38.86M	37.86M
Pension & Other Post Retirement Benefits	8.47M	8.74M	5.88M	6.3M	6.42M
Deferred Tax Liability Non Current	22.67M	17.91M	20.54M	14.59M	9.13M
Other Non Current Liabilities	8.97M	9.42M	1.67M	1.76M	1.62M
Total Liabilities	821M	1B	822M	821M	799M
Common Stock, Total	92.19M	92.19M	92.19M	92.19M	92.19M
Retained Earnings	63.06M	129M	132M	143M	-59.24M
Comprehensive Income and Other	111M	111M	112M	112M	114M
Total Common Equity	266M	332M	337M	347M	146M
Total Equity	266M	332M	337M	347M	146M
Total Liabilities And Equity	1.09B	1.34B	1.16B	1.17B	945M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.22M	9.22M	9.22M	9.22M	9.22M
ECS Total Common Shares Outstanding	9.22M	9.22M	9.22M	9.22M	9.22M
Book Value / Share	28.87	36.03	36.54	37.67	15.89
Tangible Book Value	266M	332M	337M	347M	146M
Tangible Book Value Per Share	28.87	36.03	36.54	37.67	15.89
Total Debt	125M	265M	311M	443M	400M
Net Debt	104M	83.97M	305M	441M	397M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	9.84M	9.85M
Debt Equivalent Oper. Leases	2.75M	3.66M	1.46M	3.15M	2.76M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	397M	239M	307M	162M	232M
Inventories - Work In Process, Total	-	197M	154M	332M	268M
Land - (BS)	1.23M	1.22M	1.22M	1.22M	1.22M
Buildings, Total	43.3M	43.3M	-	47.7M	47.7M
Machinery, Total	309M	346M	421M	447M	458M
Full Time Employees	87	66	72	79	57

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	17.8M	66.39M	12.52M	10.27M	-202M
Depreciation & Amortization - CF	18.07M	20.16M	23.73M	-354K	25.02M
Depreciation & Amortization, Total	18.07M	20.16M	23.73M	-354K	25.02M
(Gain) Loss on Sale of Investments - (CF)	-	-	22K	-481K	-247K
Other Operating Activities, Total	70.29M	14.94M	15.62M	11.33M	52.53M
Change In Accounts Receivable	-427M	65.16M	50.7M	35.59M	184M
Change In Inventories	-397M	-38.54M	-26.34M	-32.2M	-5.77M
Change In Accounts Payable	560M	41.04M	-263M	-26.3M	13.59M
Change in Other Net Operating Assets	70.84M	-91.99M	90.13M	-112M	48.13M
Cash from Operations	-87.12M	77.15M	-96.16M	-114M	115M
Capital Expenditure	-	-	-76.34M	-2.34M	-10.45M
Investment in Marketable and Equity Securities, Total	-78.51M	-37.34M	8.26M	-	-
Other Investing Activities, Total	462K	1.62M	1.23M	5.67M	-21.37M
Cash from Investing	-78.05M	-35.72M	-66.86M	3.33M	-31.82M
Short Term Debt Issued, Total	-	-	4.06M	139M	-
Long-Term Debt Issued, Total	125M	140M	41.69M	51.88M	2M
Total Debt Issued	125M	140M	45.75M	191M	2M
Short Term Debt Repaid, Total	-	-	-	-	-38.18M
Long-Term Debt Repaid, Total	-	-	-	-58.73M	-6.34M
Total Debt Repaid	-	-	-	-58.73M	-44.52M
Issuance of Common Stock	88.09M	-	-	-	-
Common Dividends Paid	-	-	-9.22M	-	-
Common & Preferred Stock Dividends Paid	-	-	-9.22M	-	-
Other Financing Activities, Total	-26.67M	-21.68M	-33.8M	-25.19M	-39.78M
Cash from Financing	186M	119M	2.73M	107M	-82.3M
Miscellaneous Cash Flow Adjustments	-	-1K	1K	-	1K
Net Change in Cash	20.98M	160M	-160M	-4.03M	790K
Supplemental Items
Cash Interest Paid	26.67M	21.68M	33.8M	25.19M	39.78M
Cash Income Tax Paid (Refund)	-8.52M	-	29.89M	2.53M	1.22M
Levered Free Cash Flow	-141M	120M	-259M	-133M	120M
Unlevered Free Cash Flow	-124M	133M	-242M	-109M	144M
Change In Net Working Capital	182M	-42.98M	225M	138M	-234M
Net Debt Issued / Repaid	125M	140M	45.75M	132M	-42.52M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.27	5.79	2.82	2.71	-9.95
Return on Total Capital	20.1	14.2	5.65	4.39	-15.73
Return On Equity %	13.18	22.19	3.74	3	-81.79
Return on Common Equity	13.18	22.19	3.74	3	-81.79
Margin Analysis
Gross Profit Margin %	17.85	21.67	17.05	21.8	5.04
SG&A Margin	2.32	2.63	2.86	4.29	6.98
EBITDA Margin %	3.35	6.93	3.77	4.92	-18.62
EBITA Margin %	2.61	5.87	2.65	3.35	-21.87
EBIT Margin %	2.61	5.87	2.65	3.35	-21.87
Income From Continuing Operations Margin %	0.73	3.47	0.59	0.68	-26.24
Net Income Margin %	0.73	3.47	0.59	0.68	-26.24
Net Avail. For Common Margin %	0.73	3.47	0.59	0.68	-26.24
Normalized Net Income Margin	1.04	3.06	0.6	0.13	-16.89
Levered Free Cash Flow Margin	-5.8	6.26	-12.2	-8.83	15.55
Unlevered Free Cash Flow Margin	-5.11	6.97	-11.42	-7.24	18.66
Asset Turnover
Asset Turnover	4.46	1.58	1.7	1.3	0.73
Fixed Assets Turnover	-	9.31	8.84	5.64	2.94
Receivables Turnover (Average Receivables)	-	4.85	5.95	4.51	3.34
Inventory Turnover (Average Inventory)	-	3.6	3.93	2.47	1.47
Short Term Liquidity
Current Ratio	1.16	1.08	1.17	1.16	0.91
Quick Ratio	0.6	0.57	0.48	0.42	0.18
Operating Cash Flow to Current Liabilities	-0.12	0.08	-0.13	-0.15	0.15
Days Sales Outstanding (Average Receivables)	-	75.33	61.35	81.14	109.14
Days Outstanding Inventory (Average Inventory)	-	101.43	92.97	148.14	248.15
Average Days Payable Outstanding	-	137.92	96.99	101.33	163.21
Cash Conversion Cycle (Average Days)	-	38.84	57.33	127.95	194.08
Long Term Solvency
Total Debt/Equity	46.86	79.82	92.3	127.58	273.4
Total Debt / Total Capital	31.91	44.39	48	56.06	73.22
LT Debt/Equity	13.02	5.18	14.39	11.19	25.85
Long-Term Debt / Total Capital	8.87	2.88	7.48	4.92	6.92
Total Liabilities / Total Assets	75.52	75.14	70.92	70.29	84.51
EBIT / Interest Expense	2.38	5.18	2.12	1.31	-4.39
EBITDA / Interest Expense	3.06	6.11	3.01	1.93	-3.74
(EBITDA - Capex) / Interest Expense	3.06	6.11	0.14	1.87	-4.01
Total Debt / EBITDA	1.53	2	3.89	5.96	-2.8
Net Debt / EBITDA	1.27	0.63	3.81	5.93	-2.77
Total Debt / (EBITDA - Capex)	1.53	2	85.71	6.16	-2.61
Net Debt / (EBITDA - Capex)	1.27	0.63	83.98	6.13	-2.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-21.48	11.05	-28.89	-49.03
Gross Profit, 1 Yr. Growth %	-2.09M	-4.67	-12.63	-9.08	-88.22
EBITDA, 1 Yr. Growth %	-	62.37	-39.24	1.42	-289.16
EBITA, 1 Yr. Growth %	-57.3K	76.83	-49.54	2.11	-432.93
EBIT, 1 Yr. Growth %	-57.3K	76.83	-49.54	2.11	-432.93
Earnings From Cont. Operations, 1 Yr. Growth %	-16.14K	272.89	-81.13	-18	-2.07K
Net Income, 1 Yr. Growth %	-16.14K	272.89	-81.13	-18	-2.07K
Normalized Net Income, 1 Yr. Growth %	-36.65K	130.28	-78.28	-84.47	-6.7K
Diluted EPS Before Extra, 1 Yr. Growth %	-813.16	272.89	-81.13	-18.3	-2.07K
Accounts Receivable, 1 Yr. Growth %	-	-15.25	-2.86	-10.12	-58.08
Inventory, 1 Yr. Growth %	-	9.71	6.05	6.97	1.17
Net Property, Plant and Equip., 1 Yr. Growth %	-	8.74	24.61	1.01	-5.41
Total Assets, 1 Yr. Growth %	27.13K	22.89	-13.1	0.88	-19.11
Tangible Book Value, 1 Yr. Growth %	6.57K	24.81	1.4	3.09	-57.82
Common Equity, 1 Yr. Growth %	6.57K	24.81	1.4	3.09	-57.82
Cash From Operations, 1 Yr. Growth %	284K	-71.93	-226	18.83	-273.82
Capital Expenditures, 1 Yr. Growth %	-	-	-	-96.93	-62.52
Levered Free Cash Flow, 1 Yr. Growth %	-	-184.85	-344.34	-49.36	-189.75
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-207.1	-310.21	-55.7	-231.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-6.62	-11.14	-39.79
Gross Profit, 2 Yr. CAGR %	-	14.03K	-8.74	-10.87	-67.27
EBITDA, 2 Yr. CAGR %	-	-	-0.99	-24.88	39.87
EBITA, 2 Yr. CAGR %	-	3.08K	-5.89	-32.66	84.38
EBIT, 2 Yr. CAGR %	-	3.08K	-5.89	-32.66	84.38
Earnings From Cont. Operations, 2 Yr. CAGR %	-	2.35K	-16.12	-60.67	301.5
Net Income, 2 Yr. CAGR %	-	2.35K	-16.12	-60.67	301.5
Normalized Net Income, 2 Yr. CAGR %	-	2.8K	-29.28	-81.63	220.11
Diluted EPS Before Extra, 2 Yr. CAGR %	-	415.69	-16.12	-60.74	301.5
Accounts Receivable, 2 Yr. CAGR %	-	-	-9.27	-6.56	-38.62
Inventory, 2 Yr. CAGR %	-	-	7.87	6.51	4.03
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	16.4	12.19	-2.25
Total Assets, 2 Yr. CAGR %	-	1.73K	3.22	-6.37	-9.66
Tangible Book Value, 2 Yr. CAGR %	-	812.55	12.5	2.24	-34.06
Common Equity, 2 Yr. CAGR %	-	812.55	12.5	2.24	-34.06
Cash From Operations, 2 Yr. CAGR %	-	4.92K	-40.85	22.36	9.31
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-63
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	35.47	12.14	-32.59
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	39.56	-2.67	-23.7
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-14.73	-26.16
Gross Profit, 3 Yr. CAGR %	-	-	2.49K	-8.85	-54.6
EBITDA, 3 Yr. CAGR %	-	-	-	-3.08	2.86
EBITA, 3 Yr. CAGR %	-	-	697.18	-7.33	14.72
EBIT, 3 Yr. CAGR %	-	-	697.18	-7.33	14.72
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	383.2	-16.75	44.89
Net Income, 3 Yr. CAGR %	-	-	383.2	-16.75	44.89
Normalized Net Income, 3 Yr. CAGR %	-	-	467.58	-57.33	30.56
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	71.2	-16.85	44.89
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-9.55	-28.47
Inventory, 3 Yr. CAGR %	-	-	-	7.57	4.7
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	11.03	5.99
Total Assets, 3 Yr. CAGR %	-	-	562.01	2.43	-10.82
Tangible Book Value, 3 Yr. CAGR %	-	-	338.72	9.27	-23.89
Common Equity, 3 Yr. CAGR %	-	-	338.72	9.27	-23.89
Cash From Operations, 3 Yr. CAGR %	-	-	1.36K	-25.36	14.61
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-1.88	4.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-4.25	7.58
Compound Annual Growth Rate Over Five Years
Gross Profit, 5 Yr. CAGR %	-	-	-	-	351.1
EBITA, 5 Yr. CAGR %	-	-	-	-	332.63
EBIT, 5 Yr. CAGR %	-	-	-	-	332.63
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	348.7
Net Income, 5 Yr. CAGR %	-	-	-	-	348.7
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	351.37
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	140.75
Total Assets, 5 Yr. CAGR %	-	-	-	-	198.44
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	105.58
Common Equity, 5 Yr. CAGR %	-	-	-	-	105.58
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	418.55